60
Participants
Start Date
May 31, 2011
Primary Completion Date
June 30, 2011
Matching placebo (low dose)
single dose of matching placebo
BI 207127 NA (medium dose)
Single does of BI 207127 NA
BI 207127 NA (low dose)
single dose of BI 207127 NA
Matching placebo (medium dose)
Single dose of matching placebo
BI 207127 NA (high dose)
Single dose of BI 207127 NA
Matching placebo (high dose)
Single dose of matching placebo
1241.8.8201 Boehringer Ingelheim Investigational Site, Seoul
Lead Sponsor
Boehringer Ingelheim
INDUSTRY